nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromfenac—PTGS2—Risedronate—osteoporosis	0.844	1	CbGbCtD
Bromfenac—Iritis—Ibandronate—osteoporosis	0.00979	0.0641	CcSEcCtD
Bromfenac—Sensation of foreign body—Ethinyl Estradiol—osteoporosis	0.00965	0.0632	CcSEcCtD
Bromfenac—Stinging—Calcium Acetate—osteoporosis	0.00843	0.0552	CcSEcCtD
Bromfenac—Iritis—Risedronate—osteoporosis	0.00807	0.0528	CcSEcCtD
Bromfenac—Iritis—Pamidronate—osteoporosis	0.00767	0.0502	CcSEcCtD
Bromfenac—Iritis—Zoledronate—osteoporosis	0.007	0.0459	CcSEcCtD
Bromfenac—Eye pruritus—Pamidronate—osteoporosis	0.00652	0.0427	CcSEcCtD
Bromfenac—Ocular hyperaemia—Zoledronate—osteoporosis	0.00568	0.0372	CcSEcCtD
Bromfenac—Swelling face—Conjugated Estrogens—osteoporosis	0.00538	0.0353	CcSEcCtD
Bromfenac—Ocular hyperaemia—Estradiol—osteoporosis	0.00438	0.0287	CcSEcCtD
Bromfenac—Photophobia—Calcitriol—osteoporosis	0.00342	0.0224	CcSEcCtD
Bromfenac—Asthma—Etidronic acid—osteoporosis	0.00281	0.0184	CcSEcCtD
Bromfenac—Asthma—Estropipate—osteoporosis	0.00243	0.0159	CcSEcCtD
Bromfenac—Eye irritation—Estradiol—osteoporosis	0.0024	0.0157	CcSEcCtD
Bromfenac—Asthma—Alendronate—osteoporosis	0.0024	0.0157	CcSEcCtD
Bromfenac—Asthma—Ibandronate—osteoporosis	0.00233	0.0153	CcSEcCtD
Bromfenac—Eye pain—Zoledronate—osteoporosis	0.00214	0.014	CcSEcCtD
Bromfenac—Pain—Calcium Acetate—osteoporosis	0.00208	0.0136	CcSEcCtD
Bromfenac—Asthma—Risedronate—osteoporosis	0.00192	0.0126	CcSEcCtD
Bromfenac—Pain—Ergocalciferol—osteoporosis	0.00184	0.0121	CcSEcCtD
Bromfenac—Eye disorder—Estropipate—osteoporosis	0.00182	0.0119	CcSEcCtD
Bromfenac—Mediastinal disorder—Estropipate—osteoporosis	0.00176	0.0115	CcSEcCtD
Bromfenac—Eye disorder—Ibandronate—osteoporosis	0.00175	0.0114	CcSEcCtD
Bromfenac—Mediastinal disorder—Ibandronate—osteoporosis	0.00168	0.011	CcSEcCtD
Bromfenac—Asthma—Zoledronate—osteoporosis	0.00167	0.0109	CcSEcCtD
Bromfenac—Asthma—Conjugated Estrogens—osteoporosis	0.00161	0.0105	CcSEcCtD
Bromfenac—Cough—Estropipate—osteoporosis	0.00148	0.00969	CcSEcCtD
Bromfenac—Eye disorder—Ethinyl Estradiol—osteoporosis	0.00148	0.00967	CcSEcCtD
Bromfenac—Eye disorder—Risedronate—osteoporosis	0.00144	0.00942	CcSEcCtD
Bromfenac—Cough—Raloxifene—osteoporosis	0.00143	0.00939	CcSEcCtD
Bromfenac—Mediastinal disorder—Risedronate—osteoporosis	0.00139	0.00909	CcSEcCtD
Bromfenac—Eye disorder—Pamidronate—osteoporosis	0.00137	0.00896	CcSEcCtD
Bromfenac—Mediastinal disorder—Pamidronate—osteoporosis	0.00132	0.00864	CcSEcCtD
Bromfenac—Asthma—Estradiol—osteoporosis	0.00129	0.00843	CcSEcCtD
Bromfenac—Eye disorder—Zoledronate—osteoporosis	0.00125	0.00818	CcSEcCtD
Bromfenac—Mediastinal disorder—Zoledronate—osteoporosis	0.0012	0.00789	CcSEcCtD
Bromfenac—Eye disorder—Conjugated Estrogens—osteoporosis	0.0012	0.00788	CcSEcCtD
Bromfenac—Cough—Ethinyl Estradiol—osteoporosis	0.0012	0.00786	CcSEcCtD
Bromfenac—Pain—Estropipate—osteoporosis	0.00118	0.00775	CcSEcCtD
Bromfenac—Cough—Risedronate—osteoporosis	0.00117	0.00766	CcSEcCtD
Bromfenac—Pain—Alendronate—osteoporosis	0.00117	0.00764	CcSEcCtD
Bromfenac—Mediastinal disorder—Conjugated Estrogens—osteoporosis	0.00116	0.0076	CcSEcCtD
Bromfenac—Pain—Raloxifene—osteoporosis	0.00115	0.00751	CcSEcCtD
Bromfenac—Pain—Ibandronate—osteoporosis	0.00114	0.00743	CcSEcCtD
Bromfenac—Cough—Pamidronate—osteoporosis	0.00111	0.00728	CcSEcCtD
Bromfenac—Pain—Calcitriol—osteoporosis	0.00111	0.00728	CcSEcCtD
Bromfenac—Vision blurred—Zoledronate—osteoporosis	0.0011	0.00718	CcSEcCtD
Bromfenac—Epistaxis—Estradiol—osteoporosis	0.00108	0.00709	CcSEcCtD
Bromfenac—Vision blurred—Conjugated Estrogens—osteoporosis	0.00106	0.00692	CcSEcCtD
Bromfenac—Cough—Zoledronate—osteoporosis	0.00102	0.00665	CcSEcCtD
Bromfenac—Headache—Etidronic acid—osteoporosis	0.001	0.00656	CcSEcCtD
Bromfenac—Cough—Conjugated Estrogens—osteoporosis	0.000978	0.0064	CcSEcCtD
Bromfenac—Eye disorder—Estradiol—osteoporosis	0.000963	0.00631	CcSEcCtD
Bromfenac—Pain—Risedronate—osteoporosis	0.000935	0.00613	CcSEcCtD
Bromfenac—Mediastinal disorder—Estradiol—osteoporosis	0.000929	0.00608	CcSEcCtD
Bromfenac—Pain—Pamidronate—osteoporosis	0.000889	0.00582	CcSEcCtD
Bromfenac—Headache—Estropipate—osteoporosis	0.000867	0.00568	CcSEcCtD
Bromfenac—Headache—Alendronate—osteoporosis	0.000854	0.00559	CcSEcCtD
Bromfenac—Headache—Raloxifene—osteoporosis	0.00084	0.0055	CcSEcCtD
Bromfenac—Headache—Ibandronate—osteoporosis	0.000832	0.00545	CcSEcCtD
Bromfenac—Headache—Calcitriol—osteoporosis	0.000814	0.00533	CcSEcCtD
Bromfenac—Pain—Zoledronate—osteoporosis	0.000812	0.00532	CcSEcCtD
Bromfenac—Cough—Estradiol—osteoporosis	0.000783	0.00513	CcSEcCtD
Bromfenac—Pain—Conjugated Estrogens—osteoporosis	0.000782	0.00512	CcSEcCtD
Bromfenac—Headache—Ethinyl Estradiol—osteoporosis	0.000703	0.0046	CcSEcCtD
Bromfenac—Headache—Risedronate—osteoporosis	0.000685	0.00449	CcSEcCtD
Bromfenac—Headache—Pamidronate—osteoporosis	0.000651	0.00427	CcSEcCtD
Bromfenac—Pain—Estradiol—osteoporosis	0.000626	0.0041	CcSEcCtD
Bromfenac—Headache—Zoledronate—osteoporosis	0.000595	0.0039	CcSEcCtD
Bromfenac—Headache—Conjugated Estrogens—osteoporosis	0.000573	0.00375	CcSEcCtD
Bromfenac—Headache—Estradiol—osteoporosis	0.000459	0.003	CcSEcCtD
Bromfenac—PTGS2—Synthesis of 15-eicosatetraenoic acid derivatives—GPX1—osteoporosis	0.00026	0.0742	CbGpPWpGaD
Bromfenac—PTGS1—Prostaglandin Synthesis and Regulation—ANXA2—osteoporosis	0.000242	0.069	CbGpPWpGaD
Bromfenac—PTGS2—Prostaglandin Synthesis and Regulation—ANXA2—osteoporosis	0.000192	0.0548	CbGpPWpGaD
Bromfenac—PTGS1—Selenium Micronutrient Network—PRDX3—osteoporosis	0.000148	0.0421	CbGpPWpGaD
Bromfenac—PTGS2—Calcium signaling in the CD4+ TCR pathway—NFATC1—osteoporosis	0.000137	0.039	CbGpPWpGaD
Bromfenac—PTGS2—Selenium Micronutrient Network—PRDX3—osteoporosis	0.000117	0.0334	CbGpPWpGaD
Bromfenac—PTGS1—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	9.85e-05	0.0281	CbGpPWpGaD
Bromfenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—NFATC1—osteoporosis	8.85e-05	0.0252	CbGpPWpGaD
Bromfenac—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—ACP5—osteoporosis	6.97e-05	0.0199	CbGpPWpGaD
Bromfenac—PTGS2—C-MYB transcription factor network—COL1A2—osteoporosis	6.15e-05	0.0175	CbGpPWpGaD
Bromfenac—PTGS1—Arachidonic acid metabolism—GPX1—osteoporosis	6.02e-05	0.0171	CbGpPWpGaD
Bromfenac—PTGS2—C-MYB transcription factor network—WNT1—osteoporosis	5.59e-05	0.0159	CbGpPWpGaD
Bromfenac—PTGS1—Biological oxidations—CYP27A1—osteoporosis	5.23e-05	0.0149	CbGpPWpGaD
Bromfenac—PTGS2—Signaling mediated by p38-alpha and p38-beta—ESR1—osteoporosis	5.21e-05	0.0149	CbGpPWpGaD
Bromfenac—PTGS1—Overview of nanoparticle effects—TNF—osteoporosis	5.18e-05	0.0148	CbGpPWpGaD
Bromfenac—PTGS1—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	5.18e-05	0.0148	CbGpPWpGaD
Bromfenac—PTGS2—Arachidonic acid metabolism—GPX1—osteoporosis	4.78e-05	0.0136	CbGpPWpGaD
Bromfenac—PTGS2—Aryl Hydrocarbon Receptor—ESR1—osteoporosis	4.19e-05	0.0119	CbGpPWpGaD
Bromfenac—PTGS1—Overview of nanoparticle effects—IL6—osteoporosis	4.18e-05	0.0119	CbGpPWpGaD
Bromfenac—PTGS2—Overview of nanoparticle effects—TNF—osteoporosis	4.12e-05	0.0117	CbGpPWpGaD
Bromfenac—PTGS1—Selenium Micronutrient Network—SOD2—osteoporosis	4.01e-05	0.0114	CbGpPWpGaD
Bromfenac—PTGS1—Selenium Micronutrient Network—GPX1—osteoporosis	3.83e-05	0.0109	CbGpPWpGaD
Bromfenac—PTGS1—Selenium Micronutrient Network—MTHFR—osteoporosis	3.53e-05	0.0101	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	3.5e-05	0.00997	CbGpPWpGaD
Bromfenac—PTGS2—Overview of nanoparticle effects—IL6—osteoporosis	3.32e-05	0.00947	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	3.32e-05	0.00946	CbGpPWpGaD
Bromfenac—PTGS2—Selenium Micronutrient Network—SOD2—osteoporosis	3.18e-05	0.00908	CbGpPWpGaD
Bromfenac—PTGS1—Phase 1 - Functionalization of compounds—POMC—osteoporosis	3.11e-05	0.00887	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	3.11e-05	0.00885	CbGpPWpGaD
Bromfenac—PTGS2—Selenium Micronutrient Network—GPX1—osteoporosis	3.04e-05	0.00866	CbGpPWpGaD
Bromfenac—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—osteoporosis	2.83e-05	0.00806	CbGpPWpGaD
Bromfenac—PTGS2—Selenium Micronutrient Network—MTHFR—osteoporosis	2.8e-05	0.00799	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	2.78e-05	0.00792	CbGpPWpGaD
Bromfenac—PTGS1—Biological oxidations—CYP19A1—osteoporosis	2.75e-05	0.00784	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	2.63e-05	0.00751	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	2.58e-05	0.00735	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	2.51e-05	0.00717	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	2.21e-05	0.0063	CbGpPWpGaD
Bromfenac—PTGS2—Aryl Hydrocarbon Receptor—MYC—osteoporosis	2.18e-05	0.00621	CbGpPWpGaD
Bromfenac—PTGS1—Selenium Micronutrient Network—IL1B—osteoporosis	2.1e-05	0.00597	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—LEP—osteoporosis	2.06e-05	0.00588	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	2.05e-05	0.00584	CbGpPWpGaD
Bromfenac—PTGS2—Aryl Hydrocarbon Receptor—TNF—osteoporosis	2.03e-05	0.00578	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	2.01e-05	0.00573	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	2e-05	0.00569	CbGpPWpGaD
Bromfenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—osteoporosis	1.9e-05	0.00541	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	1.71e-05	0.00487	CbGpPWpGaD
Bromfenac—PTGS2—Selenium Micronutrient Network—IL1B—osteoporosis	1.66e-05	0.00474	CbGpPWpGaD
Bromfenac—PTGS1—Biological oxidations—POMC—osteoporosis	1.65e-05	0.00471	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	1.6e-05	0.00455	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—PKM—osteoporosis	1.56e-05	0.00444	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—FDPS—osteoporosis	1.56e-05	0.00444	CbGpPWpGaD
Bromfenac—PTGS1—Selenium Micronutrient Network—TNF—osteoporosis	1.52e-05	0.00434	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—PGLS—osteoporosis	1.48e-05	0.00421	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—GPD2—osteoporosis	1.48e-05	0.00421	CbGpPWpGaD
Bromfenac—PTGS2—Disease—SOST—osteoporosis	1.48e-05	0.00421	CbGpPWpGaD
Bromfenac—PTGS2—Disease—PKM—osteoporosis	1.48e-05	0.00421	CbGpPWpGaD
Bromfenac—PTGS2—Disease—ANTXR2—osteoporosis	1.4e-05	0.00399	CbGpPWpGaD
Bromfenac—PTGS2—Disease—PGLS—osteoporosis	1.4e-05	0.00399	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	1.36e-05	0.00387	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—ATIC—osteoporosis	1.35e-05	0.00385	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—PNP—osteoporosis	1.35e-05	0.00385	CbGpPWpGaD
Bromfenac—PTGS2—C-MYB transcription factor network—MYC—osteoporosis	1.35e-05	0.00383	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	1.34e-05	0.00382	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—IL1B—osteoporosis	1.32e-05	0.00375	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—FDPS—osteoporosis	1.24e-05	0.00353	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—PKM—osteoporosis	1.24e-05	0.00353	CbGpPWpGaD
Bromfenac—PTGS1—Selenium Micronutrient Network—IL6—osteoporosis	1.23e-05	0.0035	CbGpPWpGaD
Bromfenac—PTGS2—Selenium Micronutrient Network—TNF—osteoporosis	1.21e-05	0.00344	CbGpPWpGaD
Bromfenac—PTGS2—Disease—GSN—osteoporosis	1.19e-05	0.00339	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—GPD2—osteoporosis	1.17e-05	0.00334	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—PGLS—osteoporosis	1.17e-05	0.00334	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	1.16e-05	0.00331	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—OXCT1—osteoporosis	1.15e-05	0.00327	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—CA2—osteoporosis	1.15e-05	0.00327	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—MGLL—osteoporosis	1.12e-05	0.00319	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—ATIC—osteoporosis	1.07e-05	0.00306	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—PNP—osteoporosis	1.07e-05	0.00306	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.06e-05	0.00301	CbGpPWpGaD
Bromfenac—PTGS2—Disease—LRP5—osteoporosis	1.04e-05	0.00295	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—MYC—osteoporosis	1.03e-05	0.00292	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—TGFB1—osteoporosis	1.02e-05	0.00291	CbGpPWpGaD
Bromfenac—PTGS2—Disease—LRP6—osteoporosis	9.91e-06	0.00282	CbGpPWpGaD
Bromfenac—PTGS2—Selenium Micronutrient Network—IL6—osteoporosis	9.74e-06	0.00278	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—TNF—osteoporosis	9.55e-06	0.00272	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—IDH2—osteoporosis	9.52e-06	0.00271	CbGpPWpGaD
Bromfenac—PTGS2—Disease—RPL24—osteoporosis	9.52e-06	0.00271	CbGpPWpGaD
Bromfenac—PTGS2—Disease—LTF—osteoporosis	9.52e-06	0.00271	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—OXCT1—osteoporosis	9.12e-06	0.0026	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—CA2—osteoporosis	9.12e-06	0.0026	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—CYP27A1—osteoporosis	8.95e-06	0.00255	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—MGLL—osteoporosis	8.89e-06	0.00253	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—ACP5—osteoporosis	8.71e-06	0.00248	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	8.6e-06	0.00245	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	8.38e-06	0.00239	CbGpPWpGaD
Bromfenac—PTGS2—Disease—ACP5—osteoporosis	8.25e-06	0.00235	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—TPI1—osteoporosis	8.1e-06	0.00231	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—IL6—osteoporosis	7.71e-06	0.0022	CbGpPWpGaD
Bromfenac—PTGS2—Disease—TPI1—osteoporosis	7.67e-06	0.00219	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—P4HB—osteoporosis	7.61e-06	0.00217	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—IDH2—osteoporosis	7.56e-06	0.00215	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—GAPDH—osteoporosis	7.47e-06	0.00213	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—RAP1A—osteoporosis	7.28e-06	0.00207	CbGpPWpGaD
Bromfenac—PTGS2—Disease—P4HB—osteoporosis	7.21e-06	0.00206	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—CYP27A1—osteoporosis	7.11e-06	0.00203	CbGpPWpGaD
Bromfenac—PTGS2—Disease—GAPDH—osteoporosis	7.08e-06	0.00202	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	6.97e-06	0.00199	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	6.96e-06	0.00198	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—ACP5—osteoporosis	6.91e-06	0.00197	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	6.83e-06	0.00195	CbGpPWpGaD
Bromfenac—PTGS2—Disease—NFATC1—osteoporosis	6.73e-06	0.00192	CbGpPWpGaD
Bromfenac—PTGS2—Disease—DKK1—osteoporosis	6.68e-06	0.0019	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	6.5e-06	0.00185	CbGpPWpGaD
Bromfenac—PTGS2—Disease—WNT1—osteoporosis	6.43e-06	0.00183	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—TPI1—osteoporosis	6.43e-06	0.00183	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	6.35e-06	0.00181	CbGpPWpGaD
Bromfenac—PTGS2—Disease—FGA—osteoporosis	6.26e-06	0.00178	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—P4HB—osteoporosis	6.04e-06	0.00172	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—GAPDH—osteoporosis	5.93e-06	0.00169	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—ENO1—osteoporosis	5.88e-06	0.00168	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—PSMA5—osteoporosis	5.8e-06	0.00165	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—PSMA2—osteoporosis	5.8e-06	0.00165	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—RAP1A—osteoporosis	5.78e-06	0.00165	CbGpPWpGaD
Bromfenac—PTGS2—Disease—ENO1—osteoporosis	5.58e-06	0.00159	CbGpPWpGaD
Bromfenac—PTGS2—Disease—PSMA2—osteoporosis	5.49e-06	0.00157	CbGpPWpGaD
Bromfenac—PTGS2—Disease—PSMA5—osteoporosis	5.49e-06	0.00157	CbGpPWpGaD
Bromfenac—PTGS2—Disease—CALCA—osteoporosis	5.12e-06	0.00146	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	5.04e-06	0.00144	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—CYP19A1—osteoporosis	4.7e-06	0.00134	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—ENO1—osteoporosis	4.67e-06	0.00133	CbGpPWpGaD
Bromfenac—PTGS2—Disease—KL—osteoporosis	4.65e-06	0.00133	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—PSMA2—osteoporosis	4.6e-06	0.00131	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—PSMA5—osteoporosis	4.6e-06	0.00131	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—ADCY5—osteoporosis	3.84e-06	0.0011	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—GPX1—osteoporosis	3.83e-06	0.00109	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—CYP19A1—osteoporosis	3.73e-06	0.00106	CbGpPWpGaD
Bromfenac—PTGS2—Disease—ADCY5—osteoporosis	3.64e-06	0.00104	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—MTHFR—osteoporosis	3.53e-06	0.00101	CbGpPWpGaD
Bromfenac—PTGS2—Disease—MTHFR—osteoporosis	3.35e-06	0.000955	CbGpPWpGaD
Bromfenac—PTGS2—Disease—IRS2—osteoporosis	3.19e-06	0.000908	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—ADCY5—osteoporosis	3.05e-06	0.000869	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—GPX1—osteoporosis	3.04e-06	0.000866	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—POMC—osteoporosis	2.83e-06	0.000805	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—MTHFR—osteoporosis	2.81e-06	0.0008	CbGpPWpGaD
Bromfenac—PTGS2—Disease—IRS1—osteoporosis	2.78e-06	0.000793	CbGpPWpGaD
Bromfenac—PTGS2—Disease—IL6R—osteoporosis	2.61e-06	0.000745	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—POMC—osteoporosis	2.24e-06	0.000639	CbGpPWpGaD
Bromfenac—PTGS2—Disease—MYC—osteoporosis	1.55e-06	0.000441	CbGpPWpGaD
Bromfenac—PTGS2—Disease—TGFB1—osteoporosis	1.54e-06	0.00044	CbGpPWpGaD
Bromfenac—PTGS2—Disease—IL6—osteoporosis	1.16e-06	0.000332	CbGpPWpGaD
